Furthermore, ADAM8 has been linked to chemoresistance in solid cancers [9] and tyrosine kinase inhibitor therapy resistance in chronic myeloid leukemia cells [49]. The gene discussed is ADAM8; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.